The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 27, 2011
Filed:
Jul. 30, 2005
Lynne Canne Bannen, Pacifica, CA (US);
Jeff Chen, San Francisco, CA (US);
Lisa Esther Dalrymple, San Francisco, CA (US);
Brenton T Flatt, Poway, CA (US);
Timothy Patrick Forsyth, Hayward, CA (US);
Xiao-hui Gu, San Diego, CA (US);
Morrison B Mac, San Francisco, CA (US);
Larry W Mann, Richland, MI (US);
Grace Mann, Brisbane, CA (US);
Richard Martin, San Diego, CA (US);
Raju Mohan, Encinitas, CA (US);
Brett Murphy, Lake Elsinore, CA (US);
Michael Charles Nyman, San Diego, CA (US);
William C Stevens, Escondido, CA (US);
Tie-lin Wang, San Diego, CA (US);
Yong Wang, Foster City, CA (US);
Jason H Wu, San Diego, CA (US);
Lynne Canne Bannen, Pacifica, CA (US);
Jeff Chen, San Francisco, CA (US);
Lisa Esther Dalrymple, San Francisco, CA (US);
Brenton T Flatt, Poway, CA (US);
Timothy Patrick Forsyth, Hayward, CA (US);
Xiao-Hui Gu, San Diego, CA (US);
Morrison B Mac, San Francisco, CA (US);
Larry W Mann, Richland, MI (US);
Grace Mann, Brisbane, CA (US);
Richard Martin, San Diego, CA (US);
Raju Mohan, Encinitas, CA (US);
Brett Murphy, Lake Elsinore, CA (US);
Michael Charles Nyman, San Diego, CA (US);
William C Stevens, Escondido, CA (US);
Tie-Lin Wang, San Diego, CA (US);
Yong Wang, Foster City, CA (US);
Jason H Wu, San Diego, CA (US);
Exelixis, Inc., South San Francisco, CA (US);
Abstract
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.